Associate Director (SME), WuXi Biologics CRO Services
BIOGRAPHY
Speaker
Event Date & Time
Date: October 16, 2025
Time: 2:00 PM BST | 3:00 PM CEST
Abstract
Standard bioassays often fall short when evaluating T cell engagers due to their diverse mechanisms of actions (MOAs) and functional complexity. To generate meaningful preclinical data, context-specific in vitro models are essential.
In this webinar, we will explore the strategic application of tailored bioassays for T cell engagers (TCEs) in oncology. Through real-world case studies, we will demonstrate how rational assay design, such as T cell activation, redirected killing, cytokine release, and target-specific inhibition, can support robust assessment of drug potency, specificity, and MOAs.
Learning Objectives
- Proven strategies for assay design, optimization, and biological interpretation in preclinical development
- How in vitro models like bispecific format evaluation can bridge discovery and translational relevance
- Practical approaches for transforming complex bioassay data into actionable insights to guide drug development
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 15, 2025 | 10:30 PM
LIVE NOW!
Join us for an exclusive behind-the-scenes look at the newest Thermo Scientific Vanquish HPLC & UHPLC Systems enhancements, re-designed based on customer needs and feedback. Discover how...
OCT 15, 2025 | 5:30 AM
In recent years, non-viral methods for cell engineering have emerged as promising alternatives to viral transduction. Amongst the virus-free technologies, electroporation is considered the g...
OCT 15, 2025 | 6:00 AM
Cell culture-produced adeno-associated viral (AAV) vectors have gained momentum as one of the most effective gene and protein delivery tools and are an integral part of both vaccine producti...
OCT 15, 2025 | 6:30 AM
Digital PCR (dPCR) is an excellent tool for rare target analysis applications because, unlike traditional PCR methods, dPCR divides samples into thousands of individual microreactions, then...
October 15, 2025 8:00 AM (PT), 11:00 AM (ET), 4:00 PM (CET)
When it comes to Western blotting (WB), there is a wide range of different detection methods, reagents, and imaging systems used within scientific communities. But what approach can help ens...
OCT 15, 2025 | 9:00 AM
C.E. CREDITS
Despite remarkable success in relapsed or refractory B-cell malignancies, CAR T-cell therapy faces significant challenges: primary resistance, relapse, and treatment-related toxicities. This...